FROM SINGLE USE TO CIRCULAR USE Increased attention from Governments, health services and industry evolving policy and regulatory frameworks
With
Jane Crowe, Vice President Asia Pacific
Cardinal Health
Neroli Manning
Managing Director, ANZ at Cardinal Health
Dan Vukelich, CEO and President,
Association of Medical Device Reprocessors (AMDR)
SEGMENT
Filmed in Sydney | September 2026
Healthcare sustainability is increasingly becoming a strategic priority, extending beyond environmental goals to influence procurement, regulation, costs and supply-chain resilience. Against this backdrop, medical device reprocessing is emerging as a potential pathway towards a more circular healthcare system.
In September 2026 at the RegConnect26 Summit, hosted by the Medical Technology Association of Australia, Dan Vukelich, President and CEO of the Association of Medical Device Reprocessors, outlined the international evolution of reprocessing, remanufacturing and refurbishment of single-use medical devices (SUDs).
Drawing on more than two decades of experience across the United States, Europe and other major healthcare markets, Vukelich explored how these models are increasingly influencing sustainability strategies, procurement policies and regulatory frameworks. Reprocessing can help reduce medical waste and emissions while improving resource efficiency and strengthening supply-chain resilience.
In an interview with Australian Health Journal, Vukelich was joined by Jane Crowe and Neroli Manning from Cardinal Health, a global medical device and healthcare company. The discussion examined the company’s experience in the United States and its plans to establish a remanufacturing facility in Newcastle.
Expected to open in 2027, the facility will be among the few in Australia capable of remanufacturing single-use medical devices, with products returned to circulation following quality testing and high-level disinfection processes.
Vukelich highlighted the need for greater regulatory clarity around cleaning validation, cycle limits and demonstrating that reprocessed devices meet medical device manufacturing standards. “These devices are as safe and as effective as original equipment,” he said.
The speakers also identified opportunities for Australia to develop green MedTech manufacturing capabilities and potentially expand sustainable healthcare solutions across the Asia-Pacific region.
– Media access credit: RegConnect 2026 Summit | Medical Technology Association of Australia (MTAA)
– PowerPoint slides supplied by Association of Medical Device Reprocessors (AMDR)
Source: Written by Australian Health Journal using AI
-
Message from former Australian Health Minister Hon Greg Hunt
The Honourable Greg Hunt served in the Australian Government as Minster for Health and Aged Care from 2017, previously as Industry, Innovation and Science Minister and before that the Environment Minister.
Elected as the Member for Flinders in 2001, Greg announced his retirement from politics late 2021 and in 2022, ahead of the Federal Election, having completed 20 years as a public servant.
Australian Health Journal recently caught up with Greg in a relaxed interview at his home in the Mornington Peninsula, Victoria to hear how a 9 month sabbatical has allowed him to focus on family, fitness and future. This has even included some “brutal spin cycle classes!”.
-
Still seeking outcomes after 6th Stoma Appliance Scheme Schedule Review
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
-
Being Part of the New Health Frontier
In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.
Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.
